amfAR Funds Dr. Matthias Kretzler’s Crucial Research on New Treatments for COVID-19

Matthias Kretzler, MD and team receive a grant to study the therapeutic potential of anti-interleukin 6 agents to treat kidney cells in COVID-19 patients.